Evidence map›Paper›PMID 37312136›Full record

ArticleBMC palliative care2023

Quality of life and depression in patients with amyotrophic lateral sclerosis - does the country of origin matter?

Katarzyna Ciećwierska, Dorothée Lulé, Maksymilian Bielecki, Olga Helczyk, Anna Maksymowicz-Śliwińska, Julia Finsel, Krzysztof Nieporęcki, Peter M Andersen, Albert C Ludolph, Magdalena Kuźma-Kozakiewicz

Open access · goldAbstract read
In one paragraph

Article in BMC palliative care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Katarzyna CiećwierskaDepartment of Neurology, University Clinical Center of Medical University of Warsaw, Warsaw, Poland.
Dorothée LuléDepartment of Neurology, University of Ulm, Ulm, Germany.
Maksymilian BieleckiDepartment of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland.
Olga HelczykDepartment of Neurology, University of Ulm, Ulm, Germany.
Anna Maksymowicz-ŚliwińskaDepartment of Neurology, University Clinical Center of Medical University of Warsaw, Warsaw, Poland.
Julia FinselDepartment of Neurology, University of Ulm, Ulm, Germany.
Krzysztof NieporęckiDepartment of Neurology, University Clinical Center of Medical University of Warsaw, Warsaw, Poland.
Peter M AndersenInstitute of Clinical Sciences, Neuroscience, Umeå University, Umeå, Sweden.
Albert C LudolphDepartment of Neurology, University of Ulm, Ulm, Germany.
Magdalena Kuźma-KozakiewiczDepartment of Neurology, University Clinical Center of Medical University of Warsaw, Warsaw, Poland. mkuzma@wum.edu.pl.
Medical University of Warsaw · PLUniversität Ulm · DEUmeå University · SEUniwersytet SWPS · PL

Funding

Deutsche Forschungsgemeinschaft LU 336/13-2 BI 195/54-2ERA-NET-E Rare 3/IV/MAXOMOD/11.2020EU Joint Program - Neurodegenerative Disease Research project JPND; 01ED1405the Knut and Alice Wallenberg Foundation KAW #2014.0305
6 · The paper itself

Abstract

backgroundGiven the inevitable relentless progressing nature of amyotrophic lateral sclerosis (ALS), it is essential to identify factors influencing patients' wellbeing. The study aimed to prospectively assess factors influencing the quality of life (QoL) and depression in ALS patients compared to healthy controls (HCs) from Poland, Germany and Sweden and their relationship to socio-demographic and clinical factors.

methods314 ALS patients (120 from Poland, 140 from Germany, 54 from Sweden) and 311 age-, sex- and education-level-matched HCs underwent standardized interviews for quality of life, depression, functional status and pain.

resultsPatients from all three countries showed similar levels of functional impairment (ALSFRS-R). Overall, ALS patients assessed their quality of life as lower compared to HCs (p < 0.001 for the anamnestic comparative self-assessment (ACSA), p = 0.002 for the Schedule for the evaluation of the subjective quality of life - SEIQoL- direct weighting (SEIQoL-DW). Also, the German and Swedish patients, but not the Polish, reported higher depression levels than the corresponding HCs (p < 0.001). Analysis of ALS groups revealed that functional impairment was related to a lower quality of life (ACSA) and higher depression levels among German ALS patients. Longer time since diagnosis predicted lower depression and (in male subjects) higher quality of life.

conclusionsALS patients assess their quality of life and mood lower than healthy individuals within the studied countries. The relationships between clinical and demographic factors are moderated by country of provenance, which bears implications for the design and interpretation of scientific and clinical studies, which should reflect the complexity and heterogeneity of mechanisms determining QoL.

Indexed as

Amyotrophic Lateral SclerosisQuality of LifeDepressionGermanyHealth StatusHumansMaleAmyotrophic lateral sclerosisDepressionPainQuality of lifeWellbeing

Identifiers

PMID37312136
PMCPMC10262126
OpenAlexW4380484861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.